These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 21864953)
1. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]. Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953 [TBL] [Abstract][Full Text] [Related]
2. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Matsubara K; Morioka T; Kamimoto Y; Ikeda T; Katayama N; Mizutani H Intern Med; 2016; 55(6):589-95. PubMed ID: 26984073 [TBL] [Abstract][Full Text] [Related]
3. Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study. Frison L; Lombardi A; Caputo I; Semenzato G; Fabris F; Vianello F Hematology; 2019 Dec; 24(1):134-138. PubMed ID: 30355275 [TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Diz-Küçükkaya R; Hacihanefioğlu A; Yenerel M; Turgut M; Keskin H; Nalçaci M; Inanç M Blood; 2001 Sep; 98(6):1760-4. PubMed ID: 11535509 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753 [TBL] [Abstract][Full Text] [Related]
6. Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis. Moulis G; Audemard-Verger A; Arnaud L; Luxembourger C; Montastruc F; Gaman AM; Svenungsson E; Ruggeri M; Mahévas M; Gerfaud-Valentin M; Brainsky A; Michel M; Godeau B; Lapeyre-Mestre M; Sailler L Autoimmun Rev; 2016 Mar; 15(3):203-9. PubMed ID: 26708169 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665 [TBL] [Abstract][Full Text] [Related]
8. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for arterial thrombosis in antiphospholipid syndrome. Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome]. Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202 [TBL] [Abstract][Full Text] [Related]
11. The Italian Registry of Antiphospholipid Antibodies. Finazzi G Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095 [TBL] [Abstract][Full Text] [Related]
12. Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature. El-Gendy H; El-Gohary RM; Mahfouz S; Ahmed HMA; El Demerdash DM; Ragab G Platelets; 2019; 30(5):664-671. PubMed ID: 30373491 [TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
14. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies. Forastiero RR; Kordich L; Basilotta E; Carreras LO Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319 [TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681 [TBL] [Abstract][Full Text] [Related]
18. Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies. Owaidah TM; Qurashi FH; Al Nounou RM; Al Zahrani H; Al Mussa A; Tbakhi AI; Al Daama S; Elkum N; Roberts GT Hematology; 2003 Aug; 8(4):249-57. PubMed ID: 12911943 [TBL] [Abstract][Full Text] [Related]
19. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study. Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381 [TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria. Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]